Emiliangelo Ratti
Keine laufenden Positionen mehr
Profil
Dr. Emiliangelo Ratti is Chief Executive Officer at NeRRe Therapeutics Ltd.
He is on the Board of Directors at GlaxoSmithKline SpA.
Ehemalige bekannte Positionen von Emiliangelo Ratti
| Unternehmen | Position | Ende |
|---|---|---|
NeRRe Therapeutics Ltd.
 NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Vorstandsvorsitzender | - |
Inexia Ltd.
 Inexia Ltd. Medical SpecialtiesHealth Technology Inexia Ltd. develops intranasal orexin positive modulators for the treatment of narcolepsy. The company is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - |
GlaxoSmithKline SpA
 GlaxoSmithKline SpA Pharmaceuticals: MajorHealth Technology GlaxoSmithKline SpA manufactures and distributes pharmaceutical products. The firm offers prescription pharmaceuticals and vaccines, over-the-counter medicines, oral care and nutritional healthcare products. The company was founded on March 30, 1932 and is headquartered in Verona, Italy. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
GlaxoSmithKline SpA
GlaxoSmithKline SpA Pharmaceuticals: MajorHealth Technology GlaxoSmithKline SpA manufactures and distributes pharmaceutical products. The firm offers prescription pharmaceuticals and vaccines, over-the-counter medicines, oral care and nutritional healthcare products. The company was founded on March 30, 1932 and is headquartered in Verona, Italy. | Health Technology |
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Distribution Services |
Inexia Ltd.
Inexia Ltd. Medical SpecialtiesHealth Technology Inexia Ltd. develops intranasal orexin positive modulators for the treatment of narcolepsy. The company is headquartered in London, the United Kingdom. | Health Technology |
